Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

185.22
Delayed Data
As of Jul 02
 +1.36 / +0.74%
Today’s Change
150.06
Today|||52-Week Range
203.30
+0.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Operating ActivitiesNet Income / Starting Line166.5M177.7M153.3M91.3M
 
 
 
 
 
Depreciation9.8M9.4M18.5M10.6M
 
 
 
 
 
Total Other Cash Flow-94.1M20.8M104.4M8.5M
 
 
 
 
 
Funds From Operations28.1M159.8M282.8M85.5M
 
 
 
 
 
Funds From/For Other Operating Expenses-78.1M-121.7M-631.0K62.5M
 
 
 
 
 
Net Cash Flow - Operating Activities106.2M281.5M283.5M23.0M
 
 
 
 
 
 
InvestingIncrease In Investments-158.1M-174.4M-188.4M-168.6M
 
 
 
 
 
Decrease In Investments176.7M122.1M221.4M176.3M
 
 
 
 
 
Capital Expenditures-43.5M-22.7M-52.8M-57.1M
 
 
 
 
 
Other Investing - Uses0.00-628.0K121.0K0.00
 
 
 
Other Investing - Sources-44.0K-26.0K--951.0K
 
 
 
 
Net Cash Flow Investing81.0K-75.6M-57.2M-48.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-12.0M-12.0M-12.0M-12.0M
 
 
 
 
 
Net Proceeds Stock Sale276.3M-229.0M36.7M24.9M
 
 
 
 
 
Common Preferred Redeemed-156.5M-104.6M-19.5M-60.0M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing-130.4M286.3M-35.2M52.5M
 
 
 
 
 
Other Uses - Financing39.0K38.0K142.0K303.0K
 
 
 
 
 
Net Cash Flow - Financing-22.6M-59.4M-30.1M5.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash109.0K-6.4M-4.3M-6.9M
 
 
 
 
 
 
Net Change In Cash83.7M146.6M196.2M-20.3M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account